By Reuters Staff
The U.S. Food and Drug Administration has called an advisory committee meeting on Sept. 17, to discuss the adverse cardiovascular outcomes with the usage of testosterone replacement therapy.
The FDA has called for a joint meeting of the bone, reproductive and urologic drugs...
Curr Urol Rep. 2013 Dec;14(6):557-64. doi: 10.1007/s11934-013-0370-5.
The evaluation and management of testosterone deficiency: the new frontier in urology and men's health.
Conners WP 3rd1, Morgentaler A.
[h=3][/b]1Men's Health Boston, Harvard Medical School, One Brookline Place, Suite 624...